Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
暂无分享,去创建一个
Christian Peters | L. Aguayo | C. Opazo | C. Peters | Luis G. Aguayo | Scarlet Gallegos | Carla Pacheco | Carlos M. Opazo | S. Gallegos | C. Pacheco | Carla R. Pacheco
[1] E. Junn,et al. Human α-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine , 2002, Neuroscience Letters.
[2] Samrat Mukhopadhyay,et al. Structural and Dynamical Insights into the Membrane-Bound α-Synuclein , 2013, PloS one.
[3] G. Bernardi,et al. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? , 2005, Trends in pharmacological sciences.
[4] Michael Wolff,et al. Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology , 2009, Journal of neurochemistry.
[5] E. Masliah,et al. Dynamics of α‐synuclein aggregation and inhibition of pore‐like oligomer development by β‐synuclein , 2007 .
[6] Y. Itoyama,et al. Plasma membrane ion permeability induced by mutant α‐synuclein contributes to the degeneration of neural cells , 2006, Journal of neurochemistry.
[7] N. Inestrosa,et al. β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure* , 2009, The Journal of Biological Chemistry.
[8] P. Brundin,et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. , 2011, The Journal of clinical investigation.
[9] C. Lavedan. The synuclein family. , 1998, Genome research.
[10] Claudio Soto,et al. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. , 2011, Seminars in cell & developmental biology.
[11] K. Bötzel,et al. Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes , 2012, PloS one.
[12] Sanjeev Gupta,et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders , 2011, Journal of cellular and molecular medicine.
[13] A. Björklund,et al. Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo , 2012, PloS one.
[14] S. Lindquist,et al. α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.
[15] J. Trojanowski,et al. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.
[16] Claudio Soto,et al. Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.
[17] M. Parihar,et al. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. , 2009, The international journal of biochemistry & cell biology.
[18] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[19] R. Edwards,et al. The Function of α-Synuclein , 2013, Neuron.
[20] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[21] P. Spano,et al. From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease , 2012, Brain Research.
[22] J. Troncoso,et al. Endoplasmic Reticulum Stress Is Important for the Manifestations of α-Synucleinopathy In Vivo , 2012, The Journal of Neuroscience.
[23] E. Masliah,et al. The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.
[24] H. Shill,et al. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains , 2013, Experimental Neurology.
[25] R. Benz,et al. Structural properties of pore-forming oligomers of alpha-synuclein. , 2009, Journal of the American Chemical Society.
[26] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Parodi,et al. Pore- Forming Neurotoxin-Like Mechanism for A b Oligomer-Induced Synaptic Failure , 2009 .
[28] Giuseppe Battaglia,et al. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[30] Smita Patel,et al. Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates , 2005, The Journal of Neuroscience.
[31] Brian Spencer,et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.
[32] S. Arawaka,et al. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson’s disease: a review of in vivo models , 2013, Reviews in the neurosciences.
[33] A. Bertolotti,et al. Propagation of the prion phenomenon: beyond the seeding principle. , 2012, Journal of molecular biology.
[34] Ji-Eun Suk,et al. Non‐classical exocytosis of α‐synuclein is sensitive to folding states and promoted under stress conditions , 2010, Journal of neurochemistry.
[35] L. Aguayo,et al. Extracellular α‐synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane , 2015, Journal of neurochemistry.
[36] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[37] François-Xavier Theillet,et al. Efficient modification of alpha-synuclein serine 129 by protein kinase CK1 requires phosphorylation of tyrosine 125 as a priming event. , 2014, ACS chemical neuroscience.
[38] Neha Singh,et al. Advances in the treatment of Parkinson's disease , 2007, Progress in Neurobiology.
[39] J. Troncoso,et al. Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo , 2012, The Journal of Neuroscience.
[40] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[41] C. Zurzolo,et al. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. , 2013, The Biochemical journal.
[42] Ad Bax,et al. Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.
[43] J. Trojanowski,et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.
[44] Armin Giese,et al. Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding , 2007, The Journal of Neuroscience.
[45] Claudio Soto,et al. The intricate mechanisms of neurodegeneration in prion diseases. , 2011, Trends in molecular medicine.
[46] Zeger Debyser,et al. The remarkable conformational plasticity of alpha-synuclein: blessing or curse? , 2013, Trends in molecular medicine.
[47] Chris Gardiner,et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.
[48] S. Vicini,et al. α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability , 2010, The European journal of neuroscience.
[49] A. O. Andrighetti,et al. Alpha-synuclein pore forming activity upon membrane association. , 2012, Biochimica et biophysica acta.
[50] M. Parihar,et al. Mitochondrial association of alpha-synuclein causes oxidative stress , 2008, Cellular and Molecular Life Sciences.
[51] C. Soto. Transmissible Proteins: Expanding the Prion Heresy , 2012, Cell.
[52] J. Trojanowski,et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.
[53] Ronald Melki,et al. Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport , 2012, Annals of neurology.
[54] P. Brundin,et al. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[55] C. Ross,et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. , 2005, Human molecular genetics.
[56] O. Lindvall,et al. Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.
[57] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.
[58] M. Farrer,et al. Missing pieces in the Parkinson's disease puzzle , 2010, Nature Medicine.
[59] Ssang-Goo Cho,et al. Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein , 2013, Experimental & Molecular Medicine.
[60] S. Koyama,et al. Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein–coupled receptor kinase–dependent manner , 2013, Molecular biology of the cell.
[61] C. Sigurdson,et al. [Prion diseases?]. , 1985, Deutsche medizinische Wochenschrift.
[62] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.
[63] E. Masliah,et al. Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation , 2012, The FEBS journal.
[64] P. Brundin,et al. A deadly spread: cellular mechanisms of α-synuclein transfer , 2011, Cell Death and Differentiation.
[65] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[66] Robert W. Peoples,et al. Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease , 2014, Neurobiology of Aging.
[67] F. Tarazi,et al. Emerging therapies for Parkinson's disease: from bench to bedside. , 2014, Pharmacology & therapeutics.
[68] A. Winslow,et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers , 2012, Molecular Neurodegeneration.
[69] Myeong-Hee Yu,et al. Protein folding and diseases. , 2005, Journal of biochemistry and molecular biology.
[70] J. Parodi,et al. Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property , 2010, PloS one.
[71] S. Chandra,et al. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction , 2010, Proceedings of the National Academy of Sciences.
[72] Anthony H V Schapira,et al. Neurobiology and treatment of Parkinson's disease. , 2009, Trends in pharmacological sciences.
[73] K. Chung,et al. Amino acid sequence motifs and mechanistic features of the membrane translocation of α‐synuclein , 2006, Journal of neurochemistry.
[74] L. Bubacco,et al. Structural insights on physiological functions and pathological effects of ±‐synuclein , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] Ruth Nussinov,et al. Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. , 2007, Biophysical journal.
[76] D. Allsop,et al. Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] L. Bubacco,et al. Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity , 2014, Quarterly Reviews of Biophysics.